2 studies found for:    20410922 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Dexamethasone
2 Withdrawn MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: MLN9708;   Drug: Dexamethasone

Indicates status has not been verified in more than two years